JBM (Healthcare) Limited (2161.HK) has a MoatMap StockRank of 97/100 based on Quality (71/100), Value (68/100), and Momentum (39/100) factor scores. The current signal is STRONG BUY. While a healthcare company with a quality score of 72 suggests a decent business, there is no specific macro tailwind identified that creates an asymmetric opportunity, nor is there sufficient information to confirm a robust, un-copyable moat or long reinvestment runway as per the Terry Smith lens.